MedFirst Healthcare Services, Inc. (TPEX:4175)
Taiwan · Delayed Price · Currency is TWD 50.30
+0.10 (0.20%)
Aug 19, 2026, 9:41 AM CST
TPEX:4175 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,125 | 2,510 | 2,770 | 3,646 | 2,761 | 2,442 | |
Market Cap Growth | -18.11% | -9.38% | -24.04% | 32.08% | 13.06% | 10.34% |
Enterprise Value | 5,346 | 5,763 | 6,096 | 6,616 | 5,760 | 5,559 |
Last Close Price | 50.20 | 56.01 | 60.30 | 77.72 | 62.71 | 54.47 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 16.51 | 16.14 | 39.67 | 77.90 | 16.16 | 35.94 |
Forward PE | - | 28.80 | 28.80 | 36.84 | 16.34 | 16.34 |
PS Ratio | 0.27 | 0.31 | 0.36 | 0.49 | 0.38 | 0.37 |
PB Ratio | 1.33 | 1.60 | 1.89 | 2.51 | 2.02 | 2.07 |
P/TBV Ratio | 1.36 | 1.64 | 1.94 | 2.57 | 2.08 | 2.16 |
P/FCF Ratio | 3.45 | 4.02 | 6.80 | 6.36 | 3.54 | 4.12 |
P/OCF Ratio | 2.42 | 2.78 | 5.11 | 4.58 | 2.58 | 2.44 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.67 | 0.72 | 0.79 | 0.89 | 0.80 | 0.85 |
EV/EBITDA Ratio | 5.57 | 14.50 | 19.99 | 23.04 | 14.54 | 20.83 |
EV/EBIT Ratio | 29.62 | 27.33 | 49.53 | 62.71 | 25.29 | 49.10 |
EV/FCF Ratio | 8.68 | 9.23 | 14.97 | 11.54 | 7.38 | 9.38 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 2.32 | 2.29 | 2.49 | 2.67 | 2.87 | 3.06 |
Debt / EBITDA Ratio | 3.85 | 3.63 | 4.09 | 4.57 | 4.38 | 5.14 |
Debt / FCF Ratio | 6.00 | 5.74 | 8.94 | 6.75 | 5.04 | 6.09 |
Net Debt / Equity Ratio | 2.02 | 1.97 | 2.08 | 2.00 | 2.14 | 2.35 |
Net Debt / EBITDA Ratio | 8.71 | 7.75 | 9.98 | 10.14 | 7.39 | 10.37 |
Net Debt / FCF Ratio | 5.22 | 4.93 | 7.47 | 5.08 | 3.75 | 4.67 |
Asset Turnover | 1.13 | 1.11 | 1.05 | 0.98 | 1.01 | 1.07 |
Inventory Turnover | 4.05 | 3.96 | 4.18 | 4.31 | 4.43 | 4.11 |
Quick Ratio | 0.25 | 0.28 | 0.29 | 0.41 | 0.42 | 0.42 |
Current Ratio | 0.83 | 0.83 | 0.75 | 0.85 | 0.82 | 0.87 |
Return on Equity (ROE) | 8.38% | 10.27% | 4.80% | 3.37% | 13.79% | 5.83% |
Return on Assets (ROA) | 1.59% | 1.83% | 1.04% | 0.87% | 1.98% | 1.15% |
Return on Invested Capital (ROIC) | 3.21% | 3.84% | 2.04% | 1.66% | 4.38% | 3.08% |
Return on Capital Employed (ROCE) | 4.00% | 4.60% | 3.00% | 2.30% | 5.10% | 2.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.13% | 6.20% | 2.52% | 1.28% | 6.19% | 2.78% |
FCF Yield | 29.00% | 24.88% | 14.71% | 15.73% | 28.26% | 24.28% |
Dividend Yield | 5.98% | 5.36% | 2.65% | 2.06% | 4.15% | 2.68% |
Payout Ratio | 52.03% | 43.54% | 96.82% | 224.42% | 32.99% | 95.40% |
Buyback Yield / Dilution | -0.73% | -0.72% | -0.07% | 0.18% | -0.32% | -3.20% |
Total Shareholder Return | 5.24% | 4.64% | 2.58% | 2.24% | 3.82% | -0.52% |